Enveric Biosciences Secures Key U.S. Patent to Broaden Neuropsychiatric Drug Pipeline
Enveric Biosciences, a biotechnology company developing next-generation small-molecule neuroplastogenic therapeutics, announced the issuance of a significant new U.S. patent that enhances its intellectual property portfolio and expands opportunities for advancing treatments in mental health disorders.
